WELCOME TO PANGENEX
ABOUT US
PanGenex is a publicly traded corporation (PINK SHEETS: PGXC) and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus specifically on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions throughout the population. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners throughout the U.S., fine retail establishments and the internet on websites such as www.HeartHealthyWorld.com and www.Calgenex.com.
EXECUTIVE TEAM
Jeffrey M. Roman, President and CEO
Mr. Roman brings over 12 years of management and strategic development experience in sales, marketing and executive leadership. He has a diverse background ranging from entrepreneur, CEO with Rocket City Enterprises (RCTY.PK), an automotive software provider, and manager with several automotive dealerships. At RocketCity, Mr. Roman successfully guided RocketCity through several reverse mergers and acquisitions as well as a Regulation-S offering in the European investment community raising $5.5M in capital. Previously Mr. Roman served as President of Rocket City Enterprises, Inc. and their subsidiary spin-off, Online Sales Strategies, Inc., both publicly traded companies.
Ronald P. Caputo, MD, Director
Dr. Caputo has over 20 years of expertise in cardiovascular medicine and is recognized as the nation’s foremost interventional cardiologist. Dr. Caputo is the Director of Cardiology at St. Joseph’s Hospital in Syracuse. Prior venture of AngioLink was sold to Medtronic Inc. (NYSE: MDT).
James Mosbaugh, Vice President of Brand Management and Product Development
Mr. Mosbaugh brings over 10 years of formulation chemistry experience to Calgenex and has served as Vice President and is a co-founder. From May 2005 to April 2006, Mr. Mosbaugh served as project manager and intellectual property consultant of Nanobac Pharmaceuticals (NNBP.OB). Mr. Mosbaugh has extensive expertise in the formulation of topical OTC drugs, personal care products, nutraceutical products, and sol gel chemistry.
Blake Sabatinelli, Creative Media Director
Blake Sabatinelli comes to PanGenex with over eight years of experience designing and developing for some of America's most recognizable brands, including AT&T, AOL and United Airways. Mr. Sabatinelli has extensive experience in transforming brick-and-mortar businesses into successful online enterprises utilizing a number of programming languages.
Prior to joining PanGenex, Mr. Sabatinelli operated Late Night Labs, a website design firm specializing in brand development.
ADVISORY BOARD
Joseph Jacobs, M.D., M.B.A
is the Consulting Medical Director. Dr. Jacobs received his medical degree from Yale University and his MBA from the Wharton School of Business.
Prior to his role with the Company, he served as director of the Office of Alternative Medicine at the National Institutes of Health. Dr. Jacobs has authored and/or contributed to eight books, including "Cancer: Principles and Practice of Oncology, Medical Futility and Complementary/Alternative Medicine: An Evidenced-Based Approach."